![]() Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FAM129A mRNA] | CTD | PMID:31150632 | (S)-nicotine | increases expression | ISO | RGD:736616 | 6480464 | Nicotine results in increased expression of NIBAN1 mRNA | CTD | PMID:23825647 | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | increases expression | ISO | RGD:736616 | 6480464 | o, p'-DDT results in increased expression of NIBAN1 mRNA | CTD | PMID:18204070 | 1,1-dichloroethene | increases expression | ISO | RGD:736617 | 6480464 | vinylidene chloride results in increased expression of FAM129A mRNA | CTD | PMID:26682919 | 17beta-estradiol | multiple interactions | ISO | RGD:736616 | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of FAM129A mRNA | CTD | PMID:30165855 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | RGD:736616 | 6480464 | 2 more ... | CTD | PMID:31173147 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of NIBAN1 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:736617 | 6480464 | Tetrachlorodibenzodioxin affects the expression of FAM129A mRNA | CTD | PMID:21570461 | 2,4-diaminotoluene | increases expression | ISO | RGD:736617 | 6480464 | 2, 4-diaminotoluene results in increased expression of FAM129A mRNA | CTD | PMID:20713471 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:736616 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NIBAN1 mRNA | CTD | PMID:28628672 | 3-methylcholanthrene | increases expression | ISO | RGD:736617 | 6480464 | Methylcholanthrene results in increased expression of FAM129A mRNA | CTD | PMID:20713471 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | RGD:736616 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NIBAN1 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:736617 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased expression of FAM129A mRNA | CTD | PMID:30951980 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:736617 | 6480464 | Fenretinide results in increased expression of FAM129A mRNA | CTD | PMID:28973697 | 5-azacytidine | increases expression | ISO | RGD:736616 | 6480464 | Azacitidine results in increased expression of NIBAN1 mRNA | CTD | PMID:21245298 | 5-azacytidine | multiple interactions | ISO | RGD:736616 | 6480464 | TP73 protein promotes the reaction [Azacitidine results in increased expression of NIBAN1 mRNA] | CTD | PMID:21245298 | 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:736616 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NIBAN1 mRNA | CTD | PMID:22079614 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of NIBAN1 mRNA | CTD | PMID:28959563 | aflatoxin B1 | decreases expression | ISO | RGD:736617 | 6480464 | Aflatoxin B1 results in decreased expression of FAM129A mRNA | CTD | PMID:19770486 | all-trans-retinoic acid | increases expression | ISO | RGD:736616 | 6480464 | Tretinoin results in increased expression of NIBAN1 mRNA, Tretinoin results in increased expression of NIBAN1 protein | CTD | PMID:21934132, PMID:30093655 | all-trans-retinoic acid | decreases expression | ISO | RGD:736616 | 6480464 | Tretinoin results in decreased expression of NIBAN1 mRNA | CTD | PMID:23724009 | amiodarone | increases expression | ISO | RGD:736616 | 6480464 | Amiodarone results in increased expression of NIBAN1 mRNA | CTD | PMID:19774075 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of NIBAN1 mRNA | CTD | PMID:16483693 | arsenous acid | increases expression | ISO | RGD:736616 | 6480464 | Arsenic Trioxide results in increased expression of NIBAN1 protein | CTD | PMID:30093655 | benzo[a]pyrene | decreases expression | ISO | RGD:736617 | 6480464 | Benzo(a)pyrene results in decreased expression of FAM129A mRNA | CTD | PMID:19770486 | benzo[a]pyrene | increases expression | ISO | RGD:736617 | 6480464 | Benzo(a)pyrene results in increased expression of FAM129A mRNA | CTD | PMID:22228805 | benzo[a]pyrene | decreases expression | ISO | RGD:736616 | 6480464 | Benzo(a)pyrene results in decreased expression of NIBAN1 mRNA | CTD | PMID:20064835 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | RGD:736616 | 6480464 | 7 more ... | CTD | PMID:20018196 | benzo[e]pyrene | increases methylation | ISO | RGD:736616 | 6480464 | benzo(e)pyrene results in increased methylation of NIBAN1 intron | CTD | PMID:30157460 | bicalutamide | increases expression | ISO | RGD:736616 | 6480464 | bicalutamide results in increased expression of NIBAN1 mRNA | CTD | PMID:15638997 | bisphenol A | affects expression | ISO | RGD:736616 | 6480464 | bisphenol A affects the expression of NIBAN1 mRNA | CTD | PMID:20170705 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of NIBAN1 gene | CTD | PMID:28505145 | bisphenol A | increases expression | ISO | RGD:736616 | 6480464 | bisphenol A results in increased expression of NIBAN1 mRNA | CTD | PMID:27685785, PMID:29275510 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of NIBAN1 mRNA | CTD | PMID:25181051 | bisphenol F | increases expression | ISO | RGD:736617 | 6480464 | bisphenol F results in increased expression of FAM129A mRNA | CTD | PMID:30951980 | butanal | increases expression | ISO | RGD:736616 | 6480464 | butyraldehyde results in increased expression of NIBAN1 mRNA | CTD | PMID:26079696 | calcitriol | increases expression | ISO | RGD:736616 | 6480464 | Calcitriol results in increased expression of NIBAN1 mRNA | CTD | PMID:16002434 | carbamazepine | affects expression | ISO | RGD:736616 | 6480464 | Carbamazepine affects the expression of NIBAN1 mRNA | CTD | PMID:25979313 | choline | multiple interactions | ISO | RGD:736617 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FAM129A mRNA | CTD | PMID:20938992 | cisplatin | affects response to substance | ISO | RGD:736616 | 6480464 | NIBAN1 protein affects the susceptibility to Cisplatin | CTD | PMID:16217747 | cisplatin | increases expression | ISO | RGD:736616 | 6480464 | Cisplatin results in increased expression of NIBAN1 mRNA | CTD | PMID:27594783 | clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of NIBAN1 mRNA | CTD | PMID:17602206 | cobalt dichloride | increases expression | ISO | RGD:736616 | 6480464 | cobaltous chloride results in increased expression of NIBAN1 mRNA | CTD | PMID:19376846 | cobalt dichloride | decreases expression | EXP | | 6480464 | cobaltous chloride results in decreased expression of NIBAN1 mRNA | CTD | PMID:24386269 | copper atom | multiple interactions | ISO | RGD:736616 | 6480464 | [Disulfiram binds to Copper] which results in increased expression of NIBAN1 mRNA, [NSC 689534 binds to Copper] which results in increased expression of NIBAN1 mRNA | CTD | PMID:20971185, PMID:24690739 | copper(0) | multiple interactions | ISO | RGD:736616 | 6480464 | [Disulfiram binds to Copper] which results in increased expression of NIBAN1 mRNA, [NSC 689534 binds to Copper] which results in increased expression of NIBAN1 mRNA | CTD | PMID:20971185, PMID:24690739 | cyclosporin A | increases expression | ISO | RGD:736617 | 6480464 | Cyclosporine results in increased expression of FAM129A mRNA | CTD | PMID:19770486 | cyclosporin A | increases expression | ISO | RGD:736616 | 6480464 | Cyclosporine results in increased expression of NIBAN1 mRNA | CTD | PMID:19159671 more ... | dexamethasone | decreases expression | ISO | RGD:736616 | 6480464 | Dexamethasone results in decreased expression of NIBAN1 mRNA | CTD | PMID:25047013 | dexamethasone | multiple interactions | ISO | RGD:736616 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NIBAN1 mRNA | CTD | PMID:28628672 | diarsenic trioxide | increases expression | ISO | RGD:736616 | 6480464 | Arsenic Trioxide results in increased expression of NIBAN1 protein | CTD | PMID:30093655 | disodium selenite | increases expression | ISO | RGD:736616 | 6480464 | Sodium Selenite results in increased expression of NIBAN1 mRNA | CTD | PMID:24383545 | disulfiram | multiple interactions | ISO | RGD:736616 | 6480464 | [Disulfiram binds to Copper] which results in increased expression of NIBAN1 mRNA | CTD | PMID:24690739 | dorsomorphin | multiple interactions | ISO | RGD:736616 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | RGD:736616 | 6480464 | Doxorubicin results in decreased expression of NIBAN1 mRNA | CTD | PMID:29803840 | elemental selenium | decreases expression | ISO | RGD:736616 | 6480464 | Selenium results in decreased expression of NIBAN1 mRNA | CTD | PMID:19244175 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of NIBAN1 mRNA | CTD | PMID:29391264 | entinostat | increases expression | ISO | RGD:736616 | 6480464 | entinostat results in increased expression of NIBAN1 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | RGD:736616 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NIBAN1 mRNA | CTD | PMID:27188386 | ethanol | increases expression | ISO | RGD:736616 | 6480464 | Ethanol results in increased expression of NIBAN1 mRNA | CTD | PMID:28986285 | etoposide | affects response to substance | ISO | RGD:736616 | 6480464 | NIBAN1 protein affects the susceptibility to Etoposide | CTD | PMID:16217747 | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of NIBAN1 mRNA | CTD | PMID:24793618 | folic acid | multiple interactions | ISO | RGD:736617 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FAM129A mRNA | CTD | PMID:20938992 | formaldehyde | increases expression | ISO | RGD:736616 | 6480464 | Formaldehyde results in increased expression of NIBAN1 mRNA | CTD | PMID:27664576 | genistein | multiple interactions | ISO | RGD:736616 | 6480464 | ESR1 promotes the reaction [Genistein results in increased expression of NIBAN1 protein] | CTD | PMID:20884965 | genistein | increases expression | ISO | RGD:736616 | 6480464 | Genistein results in increased expression of NIBAN1 protein | CTD | PMID:20884965 | hydroquinone | increases expression | ISO | RGD:736616 | 6480464 | hydroquinone results in increased expression of NIBAN1 mRNA | CTD | PMID:31256213 | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of NIBAN1 mRNA | CTD | PMID:21396975 | indometacin | multiple interactions | ISO | RGD:736616 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of NIBAN1 mRNA | CTD | PMID:28628672 | L-methionine | multiple interactions | ISO | RGD:736617 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of FAM129A mRNA | CTD | PMID:20938992 | lamivudine | multiple interactions | ISO | RGD:736616 | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of NIBAN1 mRNA | CTD | PMID:15784690 | lucanthone | decreases expression | ISO | RGD:736616 | 6480464 | Lucanthone results in decreased expression of NIBAN1 mRNA | CTD | PMID:21148553 | manganese(II) chloride | decreases expression | EXP | | 6480464 | manganese chloride results in decreased expression of NIBAN1 mRNA | CTD | PMID:28801915 | mercury dibromide | increases expression | ISO | RGD:736616 | 6480464 | mercuric bromide results in increased expression of NIBAN1 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | ISO | RGD:736616 | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NIBAN1 mRNA | CTD | PMID:27188386 | methapyrilene | increases methylation | ISO | RGD:736616 | 6480464 | Methapyrilene results in increased methylation of NIBAN1 intron | CTD | PMID:30157460 | methylmercury chloride | increases expression | ISO | RGD:736616 | 6480464 | methylmercuric chloride results in increased expression of NIBAN1 mRNA | CTD | PMID:28001369 | mitomycin C | affects response to substance | ISO | RGD:736616 | 6480464 | NIBAN1 protein affects the susceptibility to Mitomycin | CTD | PMID:16217747 | nicotine | increases expression | ISO | RGD:736616 | 6480464 | Nicotine results in increased expression of NIBAN1 mRNA | CTD | PMID:23825647 | pentanal | increases expression | ISO | RGD:736616 | 6480464 | pentanal results in increased expression of NIBAN1 mRNA | CTD | PMID:26079696 | phenylmercury acetate | increases expression | ISO | RGD:736616 | 6480464 | Phenylmercuric Acetate results in increased expression of NIBAN1 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:736616 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NIBAN1 mRNA | CTD | PMID:27188386 | pirinixic acid | multiple interactions | ISO | RGD:736616 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NIBAN1 mRNA | CTD | PMID:19710929 | piroxicam | decreases expression | ISO | RGD:736616 | 6480464 | Piroxicam results in decreased expression of NIBAN1 mRNA | CTD | PMID:21858171 | potassium chromate | increases expression | ISO | RGD:736616 | 6480464 | potassium chromate(VI) results in increased expression of NIBAN1 mRNA | CTD | PMID:22714537 | potassium dichromate | increases expression | ISO | RGD:736616 | 6480464 | Potassium Dichromate results in increased expression of NIBAN1 protein | CTD | PMID:23718831 | progesterone | decreases expression | ISO | RGD:736617 | 6480464 | Progesterone results in decreased expression of FAM129A mRNA | CTD | PMID:22238285 | propanal | increases expression | ISO | RGD:736616 | 6480464 | propionaldehyde results in increased expression of NIBAN1 mRNA | CTD | PMID:26079696 | SB 431542 | multiple interactions | ISO | RGD:736616 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | selenium atom | decreases expression | ISO | RGD:736616 | 6480464 | Selenium results in decreased expression of NIBAN1 mRNA | CTD | PMID:19244175 | silicon dioxide | increases expression | ISO | RGD:736616 | 6480464 | Silicon Dioxide analog results in increased expression of NIBAN1 mRNA | CTD | PMID:25895662 | silver atom | increases expression | ISO | RGD:736617 | 6480464 | Silver results in increased expression of FAM129A mRNA | CTD | PMID:27131904 | silver(0) | increases expression | ISO | RGD:736617 | 6480464 | Silver results in increased expression of FAM129A mRNA | CTD | PMID:27131904 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of NIBAN1 protein | CTD | PMID:29459688 | sodium fluoride | decreases expression | ISO | RGD:736617 | 6480464 | Sodium Fluoride results in decreased expression of FAM129A protein | CTD | PMID:28918527 | sulindac sulfide | increases expression | ISO | RGD:736616 | 6480464 | sulindac sulfide results in increased expression of NIBAN1 mRNA | CTD | PMID:12734198 | tebuconazole | decreases expression | ISO | RGD:736616 | 6480464 | tebuconazole results in decreased expression of NIBAN1 mRNA | CTD | PMID:30458266 | Tesaglitazar | decreases expression | EXP | | 6480464 | tesaglitazar results in decreased expression of NIBAN1 mRNA | CTD | PMID:21515302 | tetrachloroethene | increases expression | ISO | RGD:736617 | 6480464 | Tetrachloroethylene results in increased expression of FAM129A mRNA | CTD | PMID:28973375 | tetrachloromethane | increases expression | ISO | RGD:736617 | 6480464 | Carbon Tetrachloride results in increased expression of FAM129A mRNA | CTD | PMID:27339419 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of FAM129A mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FAM129A mRNA] | CTD | PMID:31150632 | titanium dioxide | decreases expression | ISO | RGD:736616 | 6480464 | titanium dioxide results in decreased expression of NIBAN1 protein | CTD | PMID:30910687 | titanium dioxide | increases expression | ISO | RGD:736617 | 6480464 | titanium dioxide results in increased expression of FAM129A mRNA | CTD | PMID:29264374 | topotecan | affects response to substance | ISO | RGD:736616 | 6480464 | NIBAN1 protein affects the susceptibility to Topotecan | CTD | PMID:16217747 | tris(2-butoxyethyl) phosphate | affects expression | ISO | RGD:736616 | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of NIBAN1 mRNA | CTD | PMID:29024780 | troglitazone | increases expression | EXP | | 6480464 | Troglitazone results in increased expression of NIBAN1 mRNA | CTD | PMID:21515302 | tunicamycin | increases expression | ISO | RGD:736616 | 6480464 | Tunicamycin results in increased expression of NIBAN1 mRNA | CTD | PMID:29453283 | urethane | decreases expression | ISO | RGD:736617 | 6480464 | Urethane results in decreased expression of FAM129A mRNA | CTD | PMID:16289808 | valproic acid | increases expression | ISO | RGD:736616 | 6480464 | Valproic Acid results in increased expression of NIBAN1 mRNA | CTD | PMID:19101580 more ... | vancomycin | decreases expression | ISO | RGD:736617 | 6480464 | Vancomycin results in decreased expression of FAM129A mRNA | CTD | PMID:18930951 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of NIBAN1 mRNA | CTD | PMID:23034163 | vitamin E | decreases expression | ISO | RGD:736616 | 6480464 | Vitamin E results in decreased expression of NIBAN1 mRNA | CTD | PMID:19244175 | zidovudine | multiple interactions | ISO | RGD:736616 | 6480464 | [Zidovudine co-treated with Lamivudine] results in increased expression of NIBAN1 mRNA | CTD | PMID:15784690 | zoledronic acid | increases expression | ISO | RGD:736616 | 6480464 | Zoledronic Acid results in increased expression of NIBAN1 mRNA | CTD | PMID:24714768 | |

Biological Process
Cellular Component
Molecular Function